Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

Table 3 Grade 3-4 adverse events related to chemotherapy

Toxicity	No of patients	%	No of cycles	%
Hematologic
Anemia	3	5.9	3	1.8
Neutropenia	25	49	32	18.9
Febrile neutropenia	16	31.4	17	10.1
Non-Hematologic
Gastro-intestinal
Anorexie	8	15.7	10	5.9
Constipation	1	2	1	0.6
Diarrhea	13	25.5	16	9.5
Dysphagia	1	2	1	0.6
Mucositis	6	11.8	6	3.6
Nausea	5	9.8	5	2.9
Vomiting	5	9.8	8	4.7
Constitutional
Fatigue	4	7.8	4	2.4
Hand-foot syndrome	4	7.8	6	3.6
Neurosensory
Hearing impairment	1	2	1	0.6
Neuropathy	2	3.6	2	1.2
Renal impairment	3	5.9	3	1.8